Skip to main content

Table 5 Pharmacokinetic parameters of bergapten after oral administration of 5, 10, 15 mg kg−1 (n = 8, mean ± SD)

From: The pharmacokinetics, bioavailability and excretion of bergapten after oral and intravenous administration in rats using high performance liquid chromatography with fluorescence detection

Parameters

Low (5 mg kg−1)

Medium (10 mg kg−1)

High (15 mg kg−1)

Tmax (h)

3.20 ± 0.45

3.88 ± 0.99

4.56 ± 1.40

Cmax (ng mL−1)

859.4 ± 253.6

1397 ± 573

1307 ± 617

AUC (0–tn) (ng mL−1 h−1)

3517 ± 1299

8255 ± 3536

9197 ± 5790

AUC(0–∞) (ng mL−1 h−1)

3537 ± 1302

8266 ± 3534

9306 ± 5782

V/F (L)

0.0107 ± 0.0044

0.0115 ± 0.0139

0.0124 ± 0.0138

T1/2α (h)

9.35 ± 3.07

12.88 ± 12.21

14.35 ± 15.75

MRT(0–tn) (h)

3.72 ± 0.53

4.83 ± 0.47

5.57 ± 1.15

MRT(0–∞) (h)

3.91 ± 0.51

4.87 ± 0.47

6.65 ± 2.27